"If we had had 800 (patients) already on that trial and PFS was the primary end point, it would have failed," says Lehman.
Holy cow....what a statement to make!!!
So Prima have $30m, a product that might be proven in 5+ years time after they spend.....what another $100 million??? Oh and the trial was designed to fail?????
Bizarre.
prr very much alive says matt lehman, page-2
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.5¢ | 32.0¢ | $748.2K | 2.293M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 262117 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 90114 | 6 |
View Market Depth
| Last trade - 12.33pm 25/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |